CYP17A1 and hypertensive disorder: As previous genome-wide association study (GWAS) had confirmed, the polymorphisms of CYP17A1 were associated with hypertension [25, 26] and CAD [27], and successively be proved in Asian [28–30] and Caucasian [31, 32], also in our previous studies [33, 34].